RHYTHM PHARMACEUTICALS, INC. (RYTM) Operating cash flow 2016–2025
RHYTHM PHARMACEUTICALS, INC. (RYTM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$115.7MFY2025 · since FY2016: -$23.2M → -$115.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$115.7M | -1.6% |
| FY2024 | -$113.9M | +16.4% |
| FY2023 | -$136.2M | +21.5% |
| FY2022 | -$173.4M | -18.8% |
| FY2021 | -$146.0M | -19.7% |
| FY2020 | -$122.0M | +0.6% |
| FY2019 | -$122.8M | -97.8% |
| FY2018 | -$62.1M | -110.6% |
| FY2017 | -$29.5M | -26.9% |
| FY2016 | -$23.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RYTM financial trends
RYTM RevenueRYTM Net incomeRYTM Net marginRYTM Gross profitRYTM Gross marginRYTM Operating incomeRYTM Operating marginRYTM Free cash flowRYTM Capital expendituresRYTM Return on equityRYTM Stock buybacksRYTM Dividends paidRYTM Total assetsRYTM Total liabilitiesRYTM Shareholders’ equityRYTM overview →